Becton, Dickinson and Company BDX
183.82
4.59
2.56%
as of 25 Sep
- Market cap
- $48.8B
- P/E
- 55.4×
Follow BDX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Becton, Dickinson and Company (BDX) Return on assets
Becton, Dickinson and Company's return on assets over the twelve months to 30 June 2026 was 1.78%, down 1.2 percentage points from fiscal 2025 (2.98%). Over the past ten years it has ranged from 0.35% (fiscal 2018) to 3.75% (fiscal 2016); the current reading is higher than 45% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Annual
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 2.98% | (0.12) |
| FY2024 | 3.10% | 0.41 |
| FY2023 | 2.69% | (0.47) |
| FY2022 | 3.16% | (0.55) |
| FY2021 | 3.71% | 2.26 |
| FY2020 | 1.45% | (0.60) |
| FY2019 | 2.05% | 1.70 |
| FY2018 | 0.35% | (2.90) |
| FY2017 | 3.25% | (0.50) |
| FY2016 | 3.75% | 0.18 |
Against its own ten years
Low 0.35%
High 3.75%
Ten-year median
3.10%
Current reading's percentile
45
Return on assets against peers
| Company | Return on assets |
|---|---|
| RMD ResMed Inc. compare | 17.8% |
| ISRG Intuitive Surgical, Inc. compare | 15.3% |
| WST West Pharmaceutical Services, Inc. compare | 14.1% |
| SOLV Solventum Corporation compare | 9.78% |
| MDLN Medline Inc. compare | 3.58% |
| ALC Alcon compare | 2.06% |
| BDX Becton, Dickinson and Company | 1.78% |
| RGEN Repligen Corporation compare | 1.42% |
| BAX Baxter International Inc. compare | −5.21% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on BDX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement